JORGE MALDONADO: Open Payments
NPI 1437192085 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,010 in 103 payments from 15 companies in 2025. Trend: 2023 $1,628 · 2024 $1,902 · 2025 $2,010
Food & beverage: $1,997Education: $13
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 19 | $249 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $238 |
| Alkermes, Inc. | 8 | $219 |
| Almatica Pharma LLC | 9 | $213 |
| ABBVIE INC. | 13 | $194 |
| Janssen Pharmaceuticals, Inc | 7 | $192 |
| Vanda Pharmaceuticals Inc. | 9 | $160 |
| Supernus Pharmaceuticals, Inc. | 9 | $144 |
| Collegium Pharmaceutical, Inc. | 6 | $102 |
| Axsome Therapeutics, Inc. | 4 | $84 |
Products named: REXULTI, CAPLYTA, LOREEV XR, VRAYLAR, SPRAVATO, FANAPT, Qelbree, LYBALVI.
Industry payments across TX — which companies pay providers there.
